Overcoming Endocrine Resistance in Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Lapatinib|DRUG: Aromatase Inhibitors|DRUG: Placebo Lapatinib
Sponsor: Consorzio Oncotech